Indawati DeLucca

Title: Indawati DeLucca: Innovator in Pharmaceutical Chemistry

Introduction

Indawati DeLucca is a notable inventor based in Wilmington, DE (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds aimed at treating cardiovascular diseases. With a total of 2 patents to his name, DeLucca's work has the potential to impact the medical community significantly.

Latest Patents

One of his latest patents is focused on "Amides for the treatment of atherosclerosis." This invention provides amide compounds as inhibitors of acyl-Coenzyme A: cholesterol O-acyltransferase (ACAT). The patent details pharmaceutical compositions containing such compounds, processes for their preparation, and their use as antihypercholesterolemic and/or antiatherosclerotic agents. Another significant patent is for "Angiotensin II receptor blocking imidazolinone derivatives." This patent discloses novel imidazolinone derivatives that are useful as angiotensin II antagonists.

Career Highlights

Throughout his career, Indawati DeLucca has worked with prominent companies in the pharmaceutical industry. He has been associated with the DuPont Merck Pharmaceutical Company and E.I. du Pont de Nemours and Company. His work in these organizations has allowed him to develop and refine his innovative ideas in drug development.

Collaborations

Indawati has collaborated with several professionals in his field, including George A. Boswell and Soo Sung Ko. These collaborations have likely contributed to the success of his inventions and patents.

Conclusion

Indawati DeLucca is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable patents aimed at treating serious health conditions. His contributions continue to influence the field and hold promise for future advancements in medicine.